Clinical Trial Update: Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury [Phase 2]

View source ↗

Summary

Phase 2 trial of Omegaven for total parenteral nutrition-induced cholestasis has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Parenteral Nutrition-induced Cholestasis

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Total Parenteral Nutrition-induced Cholestasis | Phase 2 | Status: COMPLETED | Results posted: 2022-11-23